Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,341
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,860
Class I recallsReasonable probability of serious health consequences
24,450
Class II recallsTemporary or medically reversible health consequences
2,901
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2

Showing 8,261–8,280 of 17,454 recalls

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Maple Spice Best by date: 01/11/20-02/2…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Maple Pecan Best by date: 01/11/20-02/…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Coconut Ginger Best by date: 01/11/20-…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Coconut Crunch Best by date: 01/11/…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Original Best by date: 01/11/20-02/2…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Gluten Free Best by date: 01/11/20-02/…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Dark Chocolate Pecan Best by date: 01/1…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall United States TerminatedTerminated: March 13, 2020Historical recordClass II

Back Roads Food Company

Product
Back Roads Granola: Ancient Grains Best by date: 01/11/20-0…
Reason
Products may contain pieces of aluminum.
Published
May 22, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 20, 2023Historical recordClass I

Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044

by Par Pharmaceutical, Inc.

Reason
Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product
Published
May 15, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 14, 2019Historical recordClass I

FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058; Manufactured by: 3M Drug Delivery Systems, St. Paul, MN 55107, NDC 47781-423-47.

by Alvogen, Inc

Reason
Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.
Published
May 15, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 28, 2020Historical recordClass II

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, NDC: 25021-701-02

by Sagent Pharmaceuticals Inc

Reason
Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.
Published
May 15, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 29, 2021Historical recordClass II

Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-093-05

by Zydus Pharmaceuticals USA Inc

Reason
Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg
Published
May 15, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 29, 2021Historical recordClass II

Acyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-791-01

by Zydus Pharmaceuticals USA Inc

Reason
Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg
Published
May 15, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 11, 2021Historical recordClass III

Dermoplast Anesthetic PAIN & ITCH (benzocaine and menthol) SPRAY canisters, 20%, 0.5%; full case of 12-2 oz. cans only; Distributed by Moberg Pharma North America LLC, Cedar Knolls, NJ 07927; Product Code 80-6802; Case UPC 1 03 16864 68002 7.

by Advantice Health

Reason
Labeling: Not Elsewhere Classified: Full cases may contain canisters that incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 11, 2021Historical recordClass III

Dermoplast Anesthetic PAIN & ITCH (benzocaine and menthol) SPRAY canisters, 20%, 0.5%, Net WT 2.75 oz (78g); Distributed by Moberg Pharma North America LLC, Cedar Knolls, NJ 07927; UPC 8 51409 00722 6

by Advantice Health

Reason
Labeling: Not Elsewhere Classified: canisters incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 6, 2020Historical recordClass II

GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21

by American Health Packaging

Reason
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 17, 2022Historical recordClass II

Revonto (dantrolene sodium for injection), 20 mg/vial, For treatment of malignant hyperthermia, For Intravenous Use Only, Rx Only, Made in Italy, Dist. by: US WorldMeds, LLC, Louisville, KY 40241, NDC: 27505-003-67

by US Worldmeds LLC

Reason
Presence of Precipitate: Appearance is Out of Specification for the reconstituted solution during 24-month stability time point analysis.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 16, 2021Historical recordClass II

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019

by Pacifico National, Inc. dba AmEx Pharmacy

Reason
Defective Delivery System: difficult to express
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets, USP, 100mg/25mg, a) 30-count (NDC: 13668-118-30) b) 90-count (NDC: 13668-118-90), c) 1000-count (NDC: 13668-118-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Published
May 8, 2019
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Losartan Potassium and Hydrochlorothiazide Tablets, USP, 100mg/12.5mg, a) 90-count (NDC: 13668-117-90), b) 1000-count (NDC: 13668-117-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Published
May 8, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.